Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MMP-2 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP227208SS
Description
MMP-2 Polyclonal specifically detects MMP-2 in Human, Canine, Equine, Feline, Primate samples. It is validated for Western Blot.Specifications
MMP-2 | |
Polyclonal | |
Unconjugated | |
0.2 ml PBS and 0.05% BSA with 0.05% Sodium Azide | |
72 kDa gelatinase, CLG4, CLG4A72 kDa type IV collagenase, collagenase type IV-A, EC 3.4.24, EC 3.4.24.24, Gelatinase A, matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IVcollagenase), matrix metalloproteinase 2 (gelatinase A, 72kD gelatinase, 72kD type IVcollagenase), Matrix metalloproteinase-2, matrix metalloproteinase-II, MMP-2, MMP-II, MONA, neutrophil gelatinase, TBE-1matrix metalloproteinase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IVcollagenase) | |
Rabbit | |
Protein G purified | |
RUO | |
Primary | |
The amino acid sequence used as immunogen for this MMP2 antibody is 100% homologous in human, horse, cat, chimpanzee, orangutan and dog, and 92% in mouse, rat, sheep and pig. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG |
Western Blot | |
0.5 mg/mL | |
Western Blot 3-5ug/ml | |
P08253 | |
MMP2 | |
A portion of amino acids 550-600 of human MMP2 was used as the immunogen for this antibody. | |
0.025 mg | |
Angiogenesis, Apoptosis, Cancer, Cell Biology, Cytoskeleton Markers, Extracellular Matrix, HIF Target Genes, Hypoxia, Tumor Suppressors | |
4313 | |
Human, Canine, Equine, Feline, Primate | |
Purified |
Product Suggestions
Customers who viewed this item also viewed
Viewing 1-5 of 8
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
MMP-2 Antibody, Novus Biologicals™ > 0.025mg; Unlabeled
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction